1996
Human Immunodeficiency Virus Infection and Infective Endocarditis among Injecting Drug Users
Manoff S, Vlahov D, Herskowitz A, Solomon L, Munoz A, Cohn S, Willoughby S, Nelson K. Human Immunodeficiency Virus Infection and Infective Endocarditis among Injecting Drug Users. Epidemiology 1996, 7: 566-570. PMID: 8899380, DOI: 10.1097/00001648-199611000-00002.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionHIV-seropositive subjectsImmunodeficiency virus infectionInfective endocarditisDrug usersCD4 cellsOdds ratioVirus infectionHistory of endocarditisRisk of endocarditisHIV-seronegative subjectsInjection drug useInjecting Drug UsersCase-control studyConditional logistic regressionRace/ethnicitySubsequent endocarditisOngoing cohortHIV infectionSerious complicationsHIV serostatusEnrollment dateLast visitCohort enrollmentEndocarditis cases
1995
Instability of Delayed-type Hypersensitivity Skin Test Anergy in Human Immunodeficiency Virus Infection
Caiaffa W, Graham N, Galai N, Rizzo R, Nelson K, Vlahov D. Instability of Delayed-type Hypersensitivity Skin Test Anergy in Human Immunodeficiency Virus Infection. JAMA Internal Medicine 1995, 155: 2111-2117. PMID: 7575072, DOI: 10.1001/archinte.1995.00430190107015.Peer-Reviewed Original ResearchConceptsHIV-seropositive subjectsHIV-seronegative subjectsCD4 cell countSkin test resultsDrug usersCell countDTH anergyDTH positivityDelayed-type hypersensitivity (DTH) skin testDelayed-type hypersensitivity anergyHuman immunodeficiency virus (HIV) infectionDTH skin testingSkin test anergyImmunodeficiency virus infectionCommunity-based cohortHuman immunodeficiency virusHypersensitivity skin testsCandida albicans antigenAnergy testingSerial skinCD4 cellsHIV statusSingle testSkin testingImmunodeficiency virusVitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users
Semba R, Caiaffa W, Graham N, Cohn S, Vlahov D. Vitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users. The Journal Of Infectious Diseases 1995, 171: 1196-1202. PMID: 7751694, DOI: 10.1093/infdis/171.5.1196.Peer-Reviewed Original ResearchConceptsInjection drug usersHuman immunodeficiency virus-infected injection drug usersDrug usersPredictors of mortalityLarge prospective cohortBody mass indexHuman immunodeficiency virusCase-control studyPlasma vitamin ACD4 cellsProspective cohortHIV infectionIndependent predictorsMass indexImmunodeficiency virusLast visitRisk factorsHigh riskVitamin AAdult subjectsMortalityInfectionMean lengthWastingVitamin